ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (OTC BB:RXHN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs, today announced that Chang H. Ahn, Ph.D., Chairman and Chief Executive Officer of the Company, will be presenting an overview of Rexahn Pharmaceuticals at The Robins Group Emerging Opportunities Investment Conference on Thursday, May 24 at 11:00 am Eastern Time at the University Club in New York City.
